| Literature DB >> 33275281 |
Antonius A de Waard1,2, Tamara Verkerk1,2, Marlieke L M Jongsma1,2,3, Kelly Hoefakker1,2, Sunesh Sethumadhavan4, Carolin Gerke5,6,7,8, Sophie Bliss1,2, Xiangrui Kong1,2, George M C Janssen9, Arnoud H de Ru9, Frans H J Claas10, Arend Mulder10, Robert Tampé4, Peter A van Veelen9, Anne Halenius5,6, Robbert M Spaapen1,2.
Abstract
Entities:
Keywords: APM; CRISPR/Cas9; HLA class I; MHC; antigen presentation
Year: 2020 PMID: 33275281 DOI: 10.1002/eji.202048599
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532